The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

Commercial weight loss programs have long been a popular option for those looking to shed a few pounds or manage their weight, but recently, they’ve evolved dramatically—parti ...

Hims & Hers Health, Inc. teams up with Novo Nordisk to offer Wegovy at $599/month, slashing costs. Click for why this is a ...

Shares of Hims & Hers Health (NYSE: HIMS) are soaring as investors react to news about the company's partnership with Novo ...

Many Americans are taking GLP1 medications, which include weight loss and diabetes medications Ozempic and Wegovy.

Before entering No.10, Sir Keir Starmer underwent a pre-election makeover courtesy of Lord Alli (the former ASOS boss gave ...

No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for bankruptcy. There’s never a dull ...

Taking the drug made one writer feel so sick she quit and focused on healthy habits instead of her body size. Turns out, 65% ...

Eli Lilly has emerged as the frontrunner in the fiercely competitive weight loss medication market, potentially outpacing rival Novo Nordisk. Recent data shows Lilly's Zepbound significantly outperfor ...

If you're one of the many people who have been interested in Ozempic-style weight loss medications but are terrified of ...

Eli Lilly gains ground with Orforglipron’s success, showing growth potential and risks from momentum and tariffs. Read why ...

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top ...